Ampli®cation of several chromosomal regions have been observed in human breast carcinomas. One such region, 8p11, is ampli®ed in 10 ± 15% of tumor samples. Although the FGFR1 gene is located close to this region, and is often included within the amplicon, the observation that tumors exhibiting 8p11 ampli®cation do not always overexpress FGFR1 suggests that another gene located close to FGFR1 is involved in the tumorigenic process. We now report the precise location of four expressed sequence tags (ESTs) within this region and the cloning of a novel gene, designated TACC1 (transforming acidic coiled coil gene 1), which encodes an 8 kb transcript and which is expressed at high levels during early embryogenesis. Constitutive expression of this gene under the control of the cytomegalovirus (CMV) promoter in mouse ®broblasts, results in cellular transformation and anchorage independent growth, suggesting that inappropriate expression can impart a proliferative advantage. This observation raises the possibility that ampli®cation of TACC1 could promote malignant growth, thereby making TACC1 an attractive candidate for the gene promoting tumorigenicity as a result of the 8p11 ampli®cation in human breast cancers.
The accumulation of genetic changes, such as structural chromosomal abnormalities, is associated with the increase in the malignant potential of cancer cells. Very often this increased malignancy is accompanied by ampli®cation of large regions of genomic DNA encompassing several genes. Once ampli®cation has occurred, it is believed that the retention of the ampli®ed region is selected for by the expression of a critical`driver' gene, which further promotes tumor growth and/or metastasis. Ampli®cations, which are frequently observed in breast carcinomas, involve regions (amplicons) in 8q24, 11q13 or 17q12, each observed in 20% of all breast tumors. The genes located within these particular amplicons have been identi®ed and encode the known proto-oncogenes, MYC (Escot et al., 1986) , CCND1 (Theillet et al., 1990) and ERBB2 (Slamon et al., 1987) , respectively.
The involvement of these genes in tumorigenesis has now been well established, and demonstrates the importance of characterising genes which are ampli®ed in breast cancer. In a search for other regions of the genome which are ampli®ed in breast cancer, an additional amplicon in 8p11 has been identi®ed in 10 ± 15% of tumors (Adnane et al., 1991 , Theillet et al., 1993 . The presence of ampli®cation in 8p11 has been associated with estrogen receptor-positive, lobular carcinomas, which metastasize to axillary lymph nodes (Adnane et al., 1991 , Courjal et al., 1997 . Although this region includes the gene, which encodes the ®broblast growth factor receptor, FGFR1, the exact involvement of this receptor in the progression of the cancer is unclear because, in some tumors, it is not included in the ampli®ed region (Dib et al., 1995) . In addition, the expression level of FGFR1 mRNA in most tumors is at comparable levels to normal breast tissue (Theillet et al., 1993) . Furthermore, in one breast tumor cell line, MDA-MB-134, which overexpresses FGFR1, treatment with FGF1 or FGF2 inhibits cell growth, suggesting that, in this cell line, overexpression of FGFR1 could be detrimental to increased tumor growth (McLeskey et al., 1994) . In fact, detailed mapping of the 8p11 amplicon suggests the potential existence of two amplicons, amplicon 1, located close to FGFR1 and a second amplicon centred around PLAT (Adelaide et al., 1998) , although concomitant ampli®cation of these two regions is also noted (Dib et al., 1995 , Adelaide et al., 1998 . However, in those tumors carrying amplicon 1 only, the minimal region implicated has been re®ned to a 600 kb region extending from the FGFR1 locus to D8S1416E (Dib et al., 1995 , Adelaide et al., 1998 . Thus, the mapping and characterisation of genes within this 600 kb region will be critical to our understanding of the mechanism by which 8p11 ampli®cation aects tumor growth and metastasis in human breast cancer. We now report the identi®cation and characterization of a novel, embryonically expressed gene from the 8p11 amplicon 1, which, upon constitutive expression in mouse fibroblasts, is capable of cellular transformation.
Prior to the latest publication of the human gene expression maps, FGFR1 was the only gene assigned to the 8p11 breast cancer amplicon. However, with the new gene mapping data, a number of additional expressed gene markers (ESTs) have been broadly assigned to the pericentromeric region of the short arm of chromosome 8 (Schuler et al., 1996) . Using primers sequences obtained from dbEST, we assigned ®ve of Figure 1 Physical map of the 380 kb region surrounding the TACC1 gene. 8p11 amplicon 1 is de®ned by the FGFR1 gene (telomeric marker) and EST D8S1416E (centromeric marker). The YACs used to map the four EST markers D8S1943, STSG33341, D8S1416E and D14665 (corresponding to the MDC-9 gene) are shown at the top of the ®gure. These markers map to BACs 311J16, 341J6 and 286P2/280P14 respectively. The presence of three CpG islands centred on NotI restriction sites (N1-3) within BAC 311J16 and 341J6 suggests the presence of at least three genes within this region. Two of these CpG islands are located close to the EST marker D8S1943 in BAC311J16. The centromeric CpG island within this BAC, however, is associated with the TACC1 gene which spans approximately 125 kb of this critical region. MDC-9 gene is located centromeric to amplicon 1, thus excluding the MDC-9 gene as a candidate driver gene Figure 2 Northern blot analysis of TACC1. (a) cDNA clone 295786 hybridized to 2 mg of polyadenylated mRNA from adult tissues (Clontech). (b) cDNA clone 309581 hybridized to polyadenylated mRNA from dierent murine developmental stages (Clontech). This clone detects a transcript expressed highest at E7, prior to down regulation between E7 and E11. The developmental multiple tissue northern (MTN) was exposed for 4 h. The adult MTN was exposed for 2 days with intensi®cation. Longer exposure of the developmental MTN revealed transcript levels comparable to those seen in adult tissues these ESTs, D8S1943, D8S1461E, WI-17448, STSG33341, and D14665, corresponding to the MDC-9 gene (Weskamp et al., 1996) to the 1.2 Mb YAC 959A4, which is known to contain the critical region of amplicon 1 (Dib et al., 1995) . Based on their presence in YAC 959A4, but their absence in YACs 676A7 and 782H11, four of these ESTs (D8S1943, D8S1461E, STSG33341 and D14665) sublocalized to the 600 kb region, which encompasses the 8p11 amplicon 1 (Figure 1) .
As a ®rst stage in the construction of a contig spanning this region, these four EST markers were then used to screen a BAC library (Research Genetics). To con®rm overlap between these clones, the end-sequences of each BAC were obtained either by using the vectorette PCR method described by Hawthorn et al. (1995) , or by direct sequencing. To ®ll the gap between 311J16 and 341J6, primers were designed from the end-sequences of both of these BACs and used to screen the BAC library. This resulted in the isolation of the 70 kb BAC 364I12, which overlapped both BAC clones. The ®nal BAC contig spans approximately 380 kb of the critical region of amplicon 1, and is summarized in Figure  1 . A 33 kb fragment between NotI site N2 and 6SP from 311J16 ( Figure 1 ) was also subcloned and the ends of this fragment (311N33) were sequenced. The sequence from the two ends of 311N33 matched two dierent UNIGENE cDNA clusters, HS30256 and HS125093, which also included IMAGE cDNA 80982, the source of EST marker STSG33341 (Figure 1 ), which is located in BAC 341J6. This demonstrated that a gene, which we have named TACC1 ± for transforming acid coiled coil gene 1 (see below) ± spans a region of approximately 125 kb, which extends from NotI Site N2 to BAC341J6, and contains both the endclone 6SP and EST STSG33341.
In order to determine the expression pro®le and transcript size of TACC1, two cDNA clones, 295786 and 309581, were selected from the corresponding human UNIGENE clusters (HS30256 and HS125093). Hybridization of IMAGE clone 295786, which contains 1.3 kb of the 3' untranslated region, to multiple tissues Northern blots (Clontech) identi®ed a single major transcript of 8 kb (Figure 2a) . In adult heart, dierential splicing may account for the dierence of approximately 300 bp in the transcript size (Figure 2 ). The 8 kb transcript was detected in all tissues tested, although comparatively lower levels of expression were observed in adult liver and lung. Sequence analysis of IMAGE cDNA clone 309581 indicated that this clone contained part of the TACC1 open reading frame. When this clone was hybridized to a murine developmental Northern blot (Clontech), a single transcript of 8 kb was also detected, which showed highest expression at embryonic day 7 (Figure 2b ). TACC1 transcript levels were then dramatically downregulated by day 11, when expression levels are comparable to those seen in adult tissues (Figure 2b ). This Northern analysis also indicated that the approximately 2 kb of sequence provided by the UNIGENE clusters was incomplete. To obtain the complete human TACC1 cDNA sequence, IMAGE clones 309581 and 295786 were hybridized to both a fetal liver/spleen cDNA library (Clontech Cat. No. HL5003a) and a fetal lung library (Stratagene). Six independent, overlapping clones were identi®ed and sequenced, which allowed a 7760 bp cDNA contig to be assembled (Figure 3 ; GenBank accession: AF049910). This sequence also joined ®ve UNIGENE Examination of the TACC1 cDNA sequence reveals a 320 nt 5' untranslated region (UTR) preceding a 2415 nt open reading frame (Figure 4a ). The nucleotide sequence surrounding the proposed initiator codon (CTCATGG) is in good agreement with the Kozak sequence for protein synthesis initiation. The TACC1 cDNA has an extensive 3' untranslated region of 4997 nt, containing a single Alu repeat between nt5195 and nt5579. Further sequence analysis of cDNA clone 80982 indicated that this clone represented a partially processed transcript, and that STSG33341 actually corresponds to sequence from the last intron of TACC1. The 3'UTR also contains the D8S1461E EST, which de®nes the centromeric boundary of the 8p11 breast cancer amplicon (Figure 4a) . A typical polyadenylation signal is located 17 nucleotides upstream of the polyadenylation site.
The TACC1 open reading frame encodes a protein of 805 amino acids with a predicted molecular mass of 87.8 kDa (Figure 4b ). The TACC1 protein is rich in serine, proline and acidic residues, the frequency of which in the ®rst 600 residues of the protein rises to 15, 8 and 17% respectively. The N-terminal 20 amino acids are particularly rich in tryptophan (25%). This domain is followed by two potential attachment sites for myristylic acid, which may indicate a potential association with the plasma membrane. No transmembrane domains or signal sequences are evident in the entire protein sequence. Indeed, two typical bipartite nuclear localization signals (Robbins et al., 1991) are located at residues 226 ± 241 and 455 ± 471, suggesting that the TACC1 protein may be localized to the nucleus (Figure 4b ). However, if TACC1 is localized to the nucleus, the absence of a de®ned DNA or RNA binding domain precludes direct interaction with nucleic acid. Secondary structure analysis of the TACC1 protein indicated that the 200 amino acid carboxy-terminus can form extensive a-helical segments. This a-helical region is predicted to adopt a coiled-coil tertiary structure, similar to the rod like domains found in proteins such as myosin. BLAST homology searches using this region revealed highest similarity, but low identity, with coiled coil domains of yeast tropomyosin and other nuclear proteins involved in mitotic spindle assembly. Located within this domain, at amino acid 730, is a potential tyrosine phosphorylation site, which may serve to regulate the conformation of the coiled coil domain. This site is also conserved in the murine orthologue of TACC1 (Still et al., unpublished) . The presence of nuclear localization signals and this coiled coil domain, therefore, suggests that TACC1 could play a role in nuclear scaolding and/or assembly of the mitotic spindle.
In order to determine whether TACC1 was part of a gene family, the TBLASTN algorithm was used to search the dbEST database for human cDNA sequences related to TACC1. The coiled coil domain identi®ed a series of partial cDNAs which could be grouped into two distinct UNIGENE cDNA clusters, HS90415 and HS104019. This suggested the existence of a family of TACC genes comprising at least three family members ( Figure 5 ). We have named these genes TACC2 and TACC3 respectively. The TACC2 coiled coil is highly related to TACC1, whilst the corresponding domain of TACC3 is more divergent. This suggests that the TACC gene family evolved from a common ancestor and has undergone two successive duplications, with the TACC1/TACC2 gene duplication arising later in evolutionary time. The conservation of this domain between these family members also indicates that this region may be critical to the function of the TACC family members, possibly through interaction between the coiled coil and other proteins. In this regard, this domain could be involved in a proposed role of TACC proteins in nuclear scaolding and/or assembly of the mitotic spindle, both of which are necessary for cell division. Interestingly, the TACC2 cDNA has been mapped as part of the genome mapping project (Schuler et al., 1996) to chromosome region 10q26, within the same interval as the FGFR2 gene, which is the site of another chromosome region ampli®ed in breast cancer (Adnane et al., 1991 , Theillet et al., 1993 .
In vitro, cell transformation can often be characterized by changes in cell morphology. To investigate the consequence of increased expression levels of TACC1, we introduced a plasmid construct containing the TACC1 ORF (nt143 ± nt2940) into murine C3H10T1/ 2 ®broblasts under the constitutively active Cytomegalovirus (CMV) promoter. The morphology of three TACC1 transfected cell clones, 10R82, 10R83 and 10R85 is shown in Figure 6 . These transfected cells were more refractile and elongated than parental C3H10T1/2 cells, and failed to form complete cell monolayers ( Figure 6 ). Thus, all stable cell lines, which by rt-PCR analysis expressed the introduced TACC1 transcript (data not shown), displayed morphology changes consistent with a transformed phenotype ( Figure 6 ).
Anchorage independent growth is a well-established characteristic of cell transformation mediated by many oncogenes, including Ras (Weyman and Stacey, 1996) , Src (Scwartz, 1997) and receptor tyrosine kinases (reviewed in Schlessinger and Ullrich, 1992) . Since TACC1-transfected cells exhibited a transformed cellular morphology, their oncogenic potential was assessed by their ability to proliferate in an Figure 6 Morphology of TACC1 transfected C3H10T1/2 mouse ®broblasts. 80% con¯uent normal mouse C3H10T1/2 ®broblasts were transfected with 100 ng TACC1 plasmid using the lipofectin-mediated DNA transfection method (Gibco-BRL) and the cells were selected with 500 mg/ml G418. Isolated G418-resistant colonies were subcloned and propagated as individual cell clones. TACC1 expression was determined by rt-PCR, according to routine protocols. The three TACC1 transfected cell lines, 10R82, 10R83 and 10R85 show signi®cant alterations in cellular morphology, as compared to normal parental C3H10T1/2 cells anchorage-independent manner. The morphologically transformed 10R82, 10R83 and 10R85 cells were each able to proliferate in soft agar (Figure 7 ). Multicellular colonies were readily observed with these three TACC1 cell lines. Anchorage-independent colonies of 10R85 and 10R83 cells were similar in size to those obtained using Ha-ras transformed 11A ®broblasts. Parental C3H10T1/2 cells failed to form colonies in these soft agar assays (Figure 7 ) although, after 14 days, predominantly single cells, and in some cases pairs of post-mitotic cells, were observed. This data, therefore, suggests that deregulation of TACC1 expression leading to overexpression of the TACC1 protein has the potential to induce cellular transformation.
In summary, we have generated a BAC contig, spanning 380 kb of the 8p11 amplicon 1 associated with breast cancer. Within this region, we have identi®ed a gene of unknown function, TACC1, which is expressed at high levels during early embryogenesis. In vitro analysis of this gene using standard cellular transformation, and soft agar assays, suggests that aberrant expression of this gene could promote alterations in cellular morphology and cellular growth. This suggests that deregulation of TACC1 gene expression directly through ampli®cation of the entire gene, or through disruption of transcriptional regulatory elements could contribute to the aggressive phenotype noted for breast tumors harbouring ampli®cation of 8p11. Interestingly, the second TACC family member, TACC2 is located close to FGFR2, in a region of chromosome 10q26 which is also ampli®ed in a small percentage of breast tumors (Adnane et al., 1991 , Courjal et al., 1997 . TACC1 and additional TACC family members are, therefore, attractive candidates as potential progression factors in breast cancer. However, the exact role of these genes in human breast cancer progression will require a more detailed analysis of the expression of these genes in breast tumors, and the identi®cation of their normal cellular functions.
